![Jonathan Leslie Tobin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Leslie Tobin
Directeur/Membre du Conseil chez
STipe Therapeutics ApS
Profil
Jonathan Leslie Tobin is currently Director at STipe Therapeutics ApS since 2019, Investment Director at Arix Bioscience, Non-Executive Director at NRG Therapeutics Ltd., Director at Pheon Therapeutics Ltd. since 2022, and Partner & Chair of the Board at Brandon Capital Partners Pty Ltd. since 2021.
Former roles include Director at Molecular Vision Ltd. from 2013 to 2016, Director at Atox Bio Ltd., Non-Executive Director at Abingdon Health Plc from 2013 to 2016, Non-Executive Director at Auspherix Ltd., Managing Director at Arix Bioscience Plc from 2016 to 2021, and Director at Mitoconix Bio Ltd., Depixus SAS, VelosBio, Inc., Quench Bio, Inc., Artios Pharma Ltd., Trustee at Autism Research Trust, and Principal at Touchstone Innovations Ltd. Education includes an undergraduate degree from the University of Oxford in 2005, a doctorate from University College London in 2008, and an MBA from Imperial College London in 2013.
Postes actifs de Jonathan Leslie Tobin
| Sociétés | Poste | Début |
|---|---|---|
STipe Therapeutics ApS
 STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Directeur/Membre du Conseil | 30/09/2019 |
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | 01/08/2021 |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Directeur/Membre du Conseil | 14/03/2022 |
NRG Therapeutics Ltd.
 NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops breakthrough solutions for neurodegenerative disorders | Directeur/Membre du Conseil | - |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Jonathan Leslie Tobin
| Sociétés | Poste | Fin |
|---|---|---|
| ARIX BIOSCIENCE PLC | Private Equity Investor | 01/04/2021 |
| ARIX BIOSCIENCE PLC | Directeur Général | 01/03/2021 |
Molecular Vision Ltd.
 Molecular Vision Ltd. Medical SpecialtiesHealth Technology Develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing | Directeur/Membre du Conseil | 23/06/2016 |
| ABINGDON HEALTH PLC | Private Equity Investor | 01/06/2016 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Jonathan Leslie Tobin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Touchstone Innovations Ltd.
 Touchstone Innovations Ltd. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Vision Ltd.
Molecular Vision Ltd. Medical SpecialtiesHealth Technology Develops low-cost, lab-quality, point of care, disposable diagnostic devices for medical testing | Health Technology |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Abingdon Health Plc
 Abingdon Health Plc Medical SpecialtiesHealth Technology Manufactures and distributes medical diagnostic devices | Health Technology |
Auspherix Ltd.
 Auspherix Ltd. BiotechnologyHealth Technology Operates an early stage anti-infectives company which develops novel antibiotics to treat resistant bacterial disease | Health Technology |
Arix Bioscience Plc
 Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
Mitoconix Bio Ltd.
 Mitoconix Bio Ltd. BiotechnologyHealth Technology Develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases | Health Technology |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops a technology for genetic and epigenetic analysis | Commercial Services |
VelosBio, Inc.
 VelosBio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting biotechnological research activities | Commercial Services |
Autism Research Trust
 Autism Research Trust Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immune-oncology therapies | Health Technology |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases | Health Technology |
NRG Therapeutics Ltd.
NRG Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops breakthrough solutions for neurodegenerative disorders | Commercial Services |
Pheon Therapeutics Ltd.
Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Health Technology |
Arix Bioscience /Venture Capital/
Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience invests in companies located in the United Kingdom. The firm focuses on the therapeutics sector. It participates in early stage capital requirements. | Finance |
